Cis-platinum complexes with a pentaerythritol derivative as the ligand, a process for their preparation and a pharmaceutical agent containing these compounds

Abstract

Abstract Compounds of the general formulae I and II <IMAGE> Formula I <IMAGE> Formula II in which R1 and R2 independently of one another represent H-(CH2)a-(O-(CH2)b)c-O, where a=0 to 4, b=1 to 4 and c=1 to 7, an alkoxy or arylalkoxy group with 1 to 20 carbon atoms, an alkane- or aralkanesulfonyloxy group with 1 to 7 carbon atoms or a tetrahydropyranyloxy radical, or R1 and R2 together represent an oxygen atom bonded in an ether-like manner or an acetal or ketal radical <IMAGE> where R3 and R4 independently of one another represent a hydrogen atom, an alkyl group with 1 to 20 carbon atoms of a phenyl group, A1 and A2 are identical and represent a hydroxyl group, chloride, bromide, iodide, nitrate, acetate, trifluoroacetate, trifluorosulfonate or perchlorate, or A1 represents sulfate or carbonate ion and A2 represents H2O, or A1 A2 together represent the dianion of an organic acid, such as oxalic, malonic, hydroxymalonic, ethylmalonic, succinic, maleic, aconitic, 3,6,9-trioxaundecanedioic, 1,1- or 1,2-cyclobutanedicarboxylic, phthalic, 3- or 4-carboxyphthalic or 3,4-dicarboxyphthalic acid, or A1 and A2 together represent a recurring anionic unit of a polymeric compound, such as dextran sulfate, chondroitin sulfate or galactan sulfate, polyglutamic acid or polyitaconic acid, and a process for their preparation and a medicament containing these compounds are described.

Inventors

• 👤 Cenek Kolar
• 👤 Hans P. Kraemer
• 👤 Konrad Dehmel

Bibliographic Details